Latest return on equity
Summit Therapeutics Return on equity
Direct answer
Summit Therapeutics's return on equity is -192.5%.
The verified market snapshot reports -192.5%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 16, 2026.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -192.5%
Explore related company data
View Summit Therapeutics's market capitalizationView Summit Therapeutics's price-to-book ratioView Summit Therapeutics's 52-week price rangeView Summit Therapeutics's profit marginView Summit Therapeutics's debt-to-equity ratioView all Summit Therapeutics key metricsReturn to Summit Therapeutics profile